This Day On The Street
Continue to site right-arrow
ADVERTISEMENT
This account is pending registration confirmation. Please click on the link within the confirmation email previously sent you to complete registration.
Need a new registration confirmation email? Click here
Stocks Under $10 with 50-100% upside potential - 14 days FREE!

LabCorp Updates 2013 Guidance And Provides Preliminary 2014 Guidance

Stocks in this article: LH

Laboratory Corporation of America ® Holdings (LabCorp ®) (NYSE: LH) today reaffirmed its prior revenue growth guidance of approximately 3% and updated its non-GAAP full year 2013 Adjusted Earnings Per Share (EPS) Excluding Amortization guidance to between $6.90 and $7.05. These preliminary figures are based on current expectations and actual results may differ. The Company expects to report final 2013 results in its fourth quarter earnings release, scheduled for February 7 th, 2014.

The Company also provided its preliminary 2014 full year guidance. For 2014, the Company expects revenue growth of approximately 2% and Non-GAAP Adjusted EPS Excluding Amortization, not including the impact of any share repurchase activity in 2014, of approximately $6.50. The Company expects to provide a final 2014 guidance range in its fourth quarter earnings release.

The Company believes the challenging operating environment will continue to negatively impact financial performance through 2014. The Company’s preliminary 2014 earnings guidance, which does not include the effect of any share repurchase activity in 2014, is also based on the anticipated negative impact from, among other factors:

  • A continued muted utilization environment;
  • Continued increases in Americans with high deductible and high co-insurance plans;
  • Ongoing government payment and reimbursement issues; and
  • Uncertainty related to the implementation of the Affordable Care Act.

“We continue to operate in a very difficult environment,” said David P. King, Chairman and CEO. “In response to these challenges, we remain firmly committed to our five-pillar strategy and will execute the following actions:

  • Revitalize and strengthen our core business by continuing our initiatives in customer service, IT and laboratory automation;
  • Execute our initiatives under our fifth strategic pillar, including implementation of BeaconLBS and our other revenue growth and diversification initiatives;
  • Focus on strategic transactions; and
  • Perform a comprehensive review of our cost structure to make sure we remain the highest-quality and most efficient provider of laboratory services.”

"Looking forward,” Mr. King added, “we continue to believe that we are uniquely positioned to deliver the critical components of success through healthcare reform: high quality, reduced cost and a central role in improving patient outcomes. We remain confident that our scale, strategy and the initiatives noted above will lead to enhanced growth and profitability in the future."

1 of 3

Select the service that is right for you!

COMPARE ALL SERVICES
Action Alerts PLUS
Try it NOW

Jim Cramer and Stephanie Link actively manage a real portfolio and reveal their money management tactics while giving advanced notice before every trade.

Product Features:
  • $2.5+ million portfolio
  • Large-cap and dividend focus
  • Intraday trade alerts from Cramer
  • Weekly roundups
TheStreet Quant Ratings
Try it NOW
Only $49.95/yr

Access the tool that DOMINATES the Russell 2000 and the S&P 500.

Product Features:
  • Buy, hold, or sell recommendations for over 4,300 stocks
  • Unlimited research reports on your favorite stocks
  • A custom stock screener
  • Upgrade/downgrade alerts
Stocks Under $10
Try it NOW

David Peltier, uncovers low dollar stocks with extraordinary upside potential that are flying under Wall Street's radar.

Product Features:
  • Model portfolio
  • Stocks trading below $10
  • Intraday trade alerts
  • Weekly roundups
Dividend Stock Advisor
Try it NOW

Jim Cramer's protege, David Peltier, identifies the best of breed dividend stocks that will pay a reliable AND significant income stream.

Product Features:
  • Diversified model portfolio of dividend stocks
  • Alerts when market news affect the portfolio
  • Bi-weekly updates with exact steps to take - BUY, HOLD, SELL
Real Money Pro
Try it NOW

All of Real Money, plus 15 more of Wall Street's sharpest minds delivering actionable trading ideas, a comprehensive look at the market, and fundamental and technical analysis.

Product Features:
  • Real Money + Doug Kass Plus 15 more Wall Street Pros
  • Intraday commentary & news
  • Ultra-actionable trading ideas
Options Profits
Try it NOW

Our options trading pros provide daily market commentary and over 100 monthly option trading ideas and strategies to help you become a well-seasoned trader.

Product Features:
  • 100+ monthly options trading ideas
  • Actionable options commentary & news
  • Real-time trading community
  • Options TV
To begin commenting right away, you can log in below using your Disqus, Facebook, Twitter, OpenID or Yahoo login credentials. Alternatively, you can post a comment as a "guest" just by entering an email address. Your use of the commenting tool is subject to multiple terms of service/use and privacy policies - see here for more details.
Submit an article to us!

Markets

DOW 17,833.70 +28.90 0.16%
S&P 500 2,070.65 +9.42 0.46%
NASDAQ 4,765.38 +16.9840 0.36%

Brokerage Partners

Rates from Bankrate.com

  • Mortgage
  • Credit Cards
  • Auto

Free Newsletters from TheStreet

My Subscriptions:

After the Bell

Before the Bell

Booyah! Newsletter

Midday Bell

TheStreet Top 10 Stories

Winners & Losers

Register for Newsletters
Top Rated Stocks Top Rated Funds Top Rated ETFs